Colorectal Cancer Panel NRAS KRAS BRAF: Comprehensive Genetic Mutation Analysis
Understanding Colorectal Cancer Genetic Testing
The Colorectal Cancer Panel NRAS KRAS BRAF represents a cutting-edge diagnostic approach in modern oncology, providing crucial genetic insights for personalized cancer treatment. This comprehensive panel analyzes three key genetic biomarkers that significantly influence colorectal cancer behavior, treatment response, and patient outcomes. By examining these specific mutations, healthcare providers can make informed decisions about targeted therapy options and predict treatment efficacy with greater accuracy.
What This Test Measures and Detects
This advanced genetic panel specifically targets and analyzes mutations in three critical oncogenes:
- NRAS Mutations: Detects alterations in the NRAS gene, which plays a vital role in cell growth signaling pathways
- KRAS Mutations: Identifies specific KRAS gene variations that affect response to EGFR-targeted therapies
- BRAF Mutations: Screens for BRAF V600E and other mutations that influence cancer aggressiveness and treatment options
The test utilizes Sanger Sequencing methodology, considered the gold standard for genetic mutation detection, ensuring high accuracy and reliability in results.
Who Should Consider This Test
Clinical Indications and Symptoms
This genetic panel is particularly valuable for individuals with:
- Newly diagnosed colorectal cancer patients seeking personalized treatment options
- Patients with metastatic colorectal cancer requiring targeted therapy guidance
- Individuals with family history of colorectal cancer or Lynch syndrome
- Patients who have experienced treatment resistance or recurrence
- Those considering anti-EGFR therapy who need mutation status confirmation
Benefits of Comprehensive Genetic Testing
Undergoing the Colorectal Cancer Panel NRAS KRAS BRAF offers numerous advantages:
- Personalized Treatment Planning: Enables oncologists to select the most effective targeted therapies based on individual genetic profiles
- Improved Treatment Outcomes: Helps avoid ineffective treatments and reduces unnecessary side effects
- Prognostic Information: Provides insights into disease progression and potential treatment responses
- Clinical Trial Eligibility: Identifies patients who may qualify for specific clinical trials and novel therapies
- Cost-Effective Care: Prevents spending on treatments unlikely to benefit specific genetic profiles
Understanding Your Test Results
Interpreting Genetic Findings
Your test results will provide detailed information about the mutation status of each gene analyzed:
- Wild-Type Results: Indicates no detectable mutations, potentially making patients eligible for EGFR-targeted therapies
- Mutated Results: Identifies specific genetic alterations that may influence treatment selection and prognosis
- Clinical Correlation: Results should always be interpreted by your oncologist in the context of your overall clinical picture
- Treatment Implications: Specific mutation patterns guide therapy decisions and predict response to various treatment options
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | Colorectal Cancer Panel NRAS KRAS BRAF |
| Discount Price | $676 USD |
| Regular Price | $900 USD |
| Turnaround Time | 7-8 Days |
| Sample Type | Tumor Tissue (Paraffin Embedded Tissue Blocks) |
| Testing Method | Sanger Sequencing |
Pre-Test Requirements and Instructions
The Colorectal Cancer Panel NRAS KRAS BRAF requires a Doctor’s prescription for testing. Please note that prescriptions are not applicable for surgery and pregnancy cases or individuals planning to travel abroad. Our team will guide you through the sample collection and submission process to ensure optimal testing conditions.
Nationwide Testing Availability
We have branches across the United States, making this essential genetic testing accessible to patients in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, and beyond. Our nationwide network ensures convenient access to advanced genetic diagnostics regardless of your location.
Take Control of Your Cancer Treatment Journey
Don’t leave your treatment decisions to chance. The Colorectal Cancer Panel NRAS KRAS BRAF provides the genetic intelligence needed to make informed decisions about your cancer care. With results available in just 7-8 days and our special discounted price of $676 USD, there’s no reason to delay this crucial testing.
Ready to take the next step in your personalized cancer care?
Call or WhatsApp us today at +1(267) 388-9828 to schedule your Colorectal Cancer Panel NRAS KRAS BRAF test. Our genetic specialists are available to answer your questions and help you begin the testing process.
Note: This test is performed on tumor tissue samples and requires proper sample preparation. Consult with your healthcare provider to ensure appropriate sample collection and submission.
